2OK1
Crystal structure of JNK3 bound to N-benzyl-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide
2OK1 の概要
| エントリーDOI | 10.2210/pdb2ok1/pdb |
| 関連するPDBエントリー | 2OJG 2OJI 2OJJ |
| 分子名称 | Mitogen-activated protein kinase 10, N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE (3 entities in total) |
| 機能のキーワード | kinase inhibitor, transferase |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Cytoplasm : P53779 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 42493.57 |
| 構造登録者 | |
| 主引用文献 | Aronov, A.M.,Baker, C.,Bemis, G.W.,Cao, J.,Chen, G.,Ford, P.J.,Germann, U.A.,Green, J.,Hale, M.R.,Jacobs, M.,Janetka, J.W.,Maltais, F.,Martinez-Botella, G.,Namchuk, M.N.,Straub, J.,Tang, Q.,Xie, X. Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors. J.Med.Chem., 50:1280-1287, 2007 Cited by PubMed Abstract: The Ras/Raf/MEK/ERK signal transduction is a key oncogenic pathway implicated in a variety of human cancers. We have identified a novel series of pyrazolylpyrroles as inhibitors of ERK. Aided by the discovery of two distinct binding modes for the pyrazolylpyrrole scaffold, structure-guided optimization culminated in the discovery of 6p, a potent and selective inhibitor of ERK. PubMed: 17300186DOI: 10.1021/jm061381f 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.4 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






